(9H-FLUOREN-9-YL)METHYL 2-OXOPYRROLIDINE-1-CARBOXYLATE, 95.0%, 25g

(2S,3R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(((2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetoxy-6-(acetoxymethyl)tetrahydro-2H-pyran-2-yl)oxy)butanoic acid, 97%, 50mg

Bis(4-fluorophenyl)sulfone, 98.0%, 10g

(S)-2-((2-(hydroxybis(4-(trifluoromethyl)phenyl)methyl)pyrrolidin-1-yl)methyl)-6-(trifluoromethyl)phenol, 98%, 100mg

Methyl 4-aminotetrahydropyran-4-carboxylate hydrochloride, 95.0%, 10g

N-Hydroxysuccinimide, min. 99%, for synthesis, 25 g, glass packaging

1-(4-Methylphenyl)ethanol, 96.0%, 5g

8-Bromo-1-(4-methoxybenzyl)-3-methyl-1H-imidazo[4,5-c]quinolin-2(3H)-one, 97.0%, 250mg

(S)-2-((tert-Butoxycarbonyl)(methyl)amino)-4-fluoro-4-methylpentanoic acid, 98%, 1g

1-Bromo-4-(cyclopropylsulfonyl)benzene, 95.0%, 250mg

(Pentafluoroethyl)benzene, 95.0%, 1g

5,6-Dimethyl-1,10-phenanthroline, 95.0%, 1g

Ziprasidone Hydrochloride Monohydrate>98.0%(HPLC)50mg